| 000 | 00829 a2200229 4500 | ||
|---|---|---|---|
| 005 | 20250517211837.0 | ||
| 264 | 0 | _c20190308 | |
| 008 | 201903s 0 0 eng d | ||
| 022 | _a1474-4465 | ||
| 024 | 7 |
_a10.1016/S1474-4422(18)30109-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan Schaik, Ivo N | |
| 245 | 0 | 0 |
_aIntravenous versus subcutaneous immunoglobulin - Authors' reply. _h[electronic resource] |
| 260 |
_bThe Lancet. Neurology _c05 2018 |
||
| 300 |
_a393-394 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aAdministration, Intravenous |
| 650 | 0 | 4 | _aImmunoglobulins, Intravenous |
| 700 | 1 | _aMielke, Orell | |
| 773 | 0 |
_tThe Lancet. Neurology _gvol. 17 _gno. 5 _gp. 393-394 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1474-4422(18)30109-1 _zAvailable from publisher's website |
| 999 |
_c28288711 _d28288711 |
||